相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Default mode network connectivity change corresponds to ketamine's delayed glutamatergic effects
Meng Li et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2020)
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Maurizio Fava et al.
MOLECULAR PSYCHIATRY (2020)
Hippocampal GABA levels correlate with retrieval performance in an associative learning paradigm
Benjamin Spurny et al.
NEUROIMAGE (2020)
Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
Thu Ha Pham et al.
PHARMACOLOGY & THERAPEUTICS (2019)
(2R,6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actions
Panos Zanos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Automated ROI-Based Labeling for Multi-Voxel Magnetic Resonance Spectroscopy Data Using FreeSurfer
Benjamin Spurny et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
Jennifer L. Phillips et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine
Chun Yang et al.
BIOLOGICAL PSYCHIATRY (2018)
7T 1H-MRS in major depressive disorder: a Ketamine Treatment Study
Jennifer W. Evans et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Panos Zanos et al.
PHARMACOLOGICAL REVIEWS (2018)
Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders A Randomized Clinical Trial
Daniel C. Javitt et al.
JAMA PSYCHIATRY (2018)
S-Ketamine Rapidly Reverses Synaptic and Vascular Deficits of Hippocampus in Genetic Animal Model of Depression
Maryam Ardalan et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state
T. Fuchs et al.
MOLECULAR PSYCHIATRY (2017)
Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects
G. M. I. Chowdhury et al.
MOLECULAR PSYCHIATRY (2017)
Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers
N. V. Kraguljac et al.
MOLECULAR PSYCHIATRY (2017)
Temporal Dynamics of Antidepressant Ketamine Effects on Glutamine Cycling Follow Regional Fingerprints of AMPA and NMDA Receptor Densities
Meng Li et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine
Marc S. Lener et al.
BIOLOGICAL PSYCHIATRY (2017)
A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder
M. S. Milak et al.
MOLECULAR PSYCHIATRY (2016)
Brain GABA Levels Across Psychiatric Disorders: A Systematic Literature Review and Meta-Analysis of 1H-MRS Studies
Remmelt R. Schur et al.
HUMAN BRAIN MAPPING (2016)
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Ronald S. Duman et al.
NATURE MEDICINE (2016)
Spatial variability and reproducibility of GABA-edited MEGA-LASER 3D-MRSI in the brain at 3T
Petra Hnilicova et al.
NMR IN BIOMEDICINE (2016)
Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
Chadi G. Abdallah et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Neurochemical and BOLD responses during neuronal activation measured in the human visual cortex at 7 Tesla
Petr Bednarik et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor
Kinga Salat et al.
NEUROPHARMACOLOGY (2015)
In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept
Carolyn I. Rodriguez et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2015)
Ketamine for depression: evidence, challenges and promise
Carlos A. Zarate et al.
WORLD PSYCHIATRY (2015)
Hippocampal volume and the rapid antidepressant effect of ketamine
Chadi G. Abdallah et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Loss of Phenotype of Parvalbumin Interneurons in Rat Prefrontal Cortex Is Involved in Antidepressant- and Propsychotic-Like Behaviors Following Acute and Repeated Ketamine Administration
ZhiQiang Zhou et al.
MOLECULAR NEUROBIOLOGY (2015)
Hippocampal volume and depressive symptoms are linked to serum IL-18 in schizophrenia
Paola Bossu et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Hippocampal multimodal structural changes and subclinical depression in healthy individuals
Gianfranco Spalletta et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Downregulation of Neuregulin 1-ErbB4 Signaling in Parvalbumin Interneurons in the Rat Brain May Contribute to the Antidepressant Properties of Ketamine
Nan Wang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2014)
3D GABA imaging with real-time motion correction, shim update and reacquisition of adiabatic spiral MRSI
Wolfgang Bogner et al.
NEUROIMAGE (2014)
Real-time motion- and Bo-correction for LASER-localized spiral-accelerated 3D-MRSI of the brain at 3 T
Wolfgang Bogner et al.
NEUROIMAGE (2014)
Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA
Paul G. Mullins et al.
NEUROIMAGE (2014)
Ketamine reverses stress-induced depression-like behavior and increased GABA levels in the anterior cingulate: An 11.7 T 1H-MRS study in rats
Shane A. Perrine et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
1H-[13C]-Nuclear Magnetic Resonance Spectroscopy Measures of Ketamine's Effect on Amino Acid Neurotransmitter Metabolism
Golam M. I. Chowdhury et al.
BIOLOGICAL PSYCHIATRY (2012)
Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression
Xiaochen Zhao et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study
Matthew J. Taylor et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine- induced psychopathology
J. M. Stone et al.
MOLECULAR PSYCHIATRY (2012)
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission
Maurizio Popoli et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Towards a glutamate hypothesis of depression An emerging frontier of neuropsychopharmacology for mood disorders
Gerard Sanacora et al.
NEUROPHARMACOLOGY (2012)
The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?
G. MacQueen et al.
MOLECULAR PSYCHIATRY (2011)
The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS
Gerald W. Valentine et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2011)
Spectroscopic imaging with improved gradient modulated constant adiabaticity pulses on high-field clinical scanners
Ovidiu C. Andronesi et al.
JOURNAL OF MAGNETIC RESONANCE (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Receptor Architecture of Human Cingulate Cortex: Evaluation of the Four-Region Neurobiological Model
Nicola Palomero-Gallagher et al.
HUMAN BRAIN MAPPING (2009)
Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs
Joanna M. Wieronska et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: an in vivo localized 1H MRS study
Isabelle Iltis et al.
NMR IN BIOMEDICINE (2009)
Cellular mechanisms underlying the antidepressant effects of ketamine:: Role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors
Sungho Maeng et al.
BIOLOGICAL PSYCHIATRY (2008)
Psychiatric safety of ketamine in psychopharmacology research
Edward B. Perry et al.
PSYCHOPHARMACOLOGY (2007)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer
Lasse K. Bak et al.
JOURNAL OF NEUROCHEMISTRY (2006)
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
Rahul S. Desikan et al.
NEUROIMAGE (2006)
Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: A 4-T proton MRS study
LM Rowland et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Increased cortical GABA concentrations in depressed patients receiving ECT
G Sanacora et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors
G Sanacora et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain
B Fischl et al.
NEURON (2002)
Attenuation of the neuropsychiatric effects of ketamine with lamotrigine -: Support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists
A Anand et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
分享论文
